Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Moreno

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Journal of Neuro-Oncology|July 13, 2011
Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicityHarsha Prasada Lashkari, Srdjan Saso, Lucas Moreno, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Preclinical drug development for childhood cancerLucas Moreno, Louis Chesler, Darren Hargrave, et al.
Journal of Pediatric Hematology/Oncology|July 23, 2015
Additional Therapies to Improve Metastatic Response to Induction Therapy in Children With High-risk NeuroblastomaDominik Schrey, Sucheta J Vaidya, Daniel Levine, et al.
Journal of Neuro-Oncology|November 9, 2012
Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymomaLucas Moreno, Sergey Popov, Alexa Jury, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|December 30, 2009
Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysisStergios Zacharoulis, Sue Ashley, Lucas Moreno, et al.
Expert Opinion on Drug Discovery|April 5, 2015
Targeted approaches to childhood cancer: progress in drug discovery and developmentSteffen Hirsch, Lynley V Marshall, Fernando Carceller Lechon, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer ConsortiumFrancisco Bautista, Lucas Moreno, Lynley Marshall, et al.
Nutricion Hospitalaria|August 2, 2019
[Lifestyle modulation of gut microbiota]Beatriz de Lucas Moreno, Rocío González Soltero, Carlo Bressa, et al.
Cancer Discovery|December 5, 2020
Opportunities and Challenges in Drug Development for Pediatric CancersTheodore W Laetsch, Steven G DuBois, Julia Glade Bender, et al.
Cancer Medicine|October 6, 2017
Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology updateFrancisco Bautista, Victoria Fioravantti, Teresa de Rojas, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Journal of Neuro-Oncology|July 13, 2011
Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicityHarsha Prasada Lashkari, Srdjan Saso, Lucas Moreno, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Preclinical drug development for childhood cancerLucas Moreno, Louis Chesler, Darren Hargrave, et al.
Journal of Pediatric Hematology/Oncology|July 23, 2015
Additional Therapies to Improve Metastatic Response to Induction Therapy in Children With High-risk NeuroblastomaDominik Schrey, Sucheta J Vaidya, Daniel Levine, et al.
Journal of Neuro-Oncology|November 9, 2012
Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymomaLucas Moreno, Sergey Popov, Alexa Jury, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|December 30, 2009
Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysisStergios Zacharoulis, Sue Ashley, Lucas Moreno, et al.
Expert Opinion on Drug Discovery|April 5, 2015
Targeted approaches to childhood cancer: progress in drug discovery and developmentSteffen Hirsch, Lynley V Marshall, Fernando Carceller Lechon, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer ConsortiumFrancisco Bautista, Lucas Moreno, Lynley Marshall, et al.
Nutricion Hospitalaria|August 2, 2019
[Lifestyle modulation of gut microbiota]Beatriz de Lucas Moreno, Rocío González Soltero, Carlo Bressa, et al.
Cancer Discovery|December 5, 2020
Opportunities and Challenges in Drug Development for Pediatric CancersTheodore W Laetsch, Steven G DuBois, Julia Glade Bender, et al.
Cancer Medicine|October 6, 2017
Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology updateFrancisco Bautista, Victoria Fioravantti, Teresa de Rojas, et al.
Pageof 13